Zhang Lin1, Zou Xiaoyi2. 1. Department of Neurology, West China Hospital, Sichuan University, Chengdu, China. 2. Department of Neurology, West China Hospital, Sichuan University, Chengdu, China. Electronic address: xiaoyizou@163.com.
Abstract
PURPOSE: To investigate the incidence rate of tranexamic acid (TXA)-associated seizures. METHODS: Two electronic databases (Medline and Embase) were searched. We looked for additional studies in the references of all identified publications. The cutoff day was 2015 Dec 06. Two authors independently reviewed the titles and abstracts of the publications identified firstly. Odds ratio (OR) and 95% confidence interval (CI) were used to compare discontinuous variables. RESULTS: Ten studies enrolling 26,079 patients with TXA exposure and 7395 patients with non-TXA exposure were included. The cumulative incidence rate of TXA-associated seizures is 2.7%. The odds ratio of seizure is 5.39 (95%CI: 3.29-8.85; I(2)=0%; P<0.001) in patients with TXA exposure vs patients with non-TXA exposure. The incidence rate of TXA-associated seizures increased when the dose levels increased. CONCLUSION: The risk of seizure increased in patients with TXA exposure and the incidence rate of TXA-associated seizures increased when the dose levels increased.
PURPOSE: To investigate the incidence rate of tranexamic acid (TXA)-associated seizures. METHODS: Two electronic databases (Medline and Embase) were searched. We looked for additional studies in the references of all identified publications. The cutoff day was 2015 Dec 06. Two authors independently reviewed the titles and abstracts of the publications identified firstly. Odds ratio (OR) and 95% confidence interval (CI) were used to compare discontinuous variables. RESULTS: Ten studies enrolling 26,079 patients with TXA exposure and 7395 patients with non-TXA exposure were included. The cumulative incidence rate of TXA-associated seizures is 2.7%. The odds ratio of seizure is 5.39 (95%CI: 3.29-8.85; I(2)=0%; P<0.001) in patients with TXA exposure vs patients with non-TXA exposure. The incidence rate of TXA-associated seizures increased when the dose levels increased. CONCLUSION: The risk of seizure increased in patients with TXA exposure and the incidence rate of TXA-associated seizures increased when the dose levels increased.
Authors: Sara Juliana de A de Vasconcellos; Edmundo M do Nascimento-Júnior; Marcel Vinícius de Aguiar Menezes; Mário Luis Tavares Mendes; Rafael de Souza Dantas; Paulo Ricardo Saquete Martins-Filho Journal: JAMA Otolaryngol Head Neck Surg Date: 2018-09-01 Impact factor: 6.223
Authors: Maria M Galardi; Jennifer M Strahle; Alex Skidmore; Akash P Kansagra; Kristin P Guilliams Journal: Pediatr Neurol Date: 2020-01-11 Impact factor: 3.372
Authors: Susan E Rowell; Eric N Meier; Barbara McKnight; Delores Kannas; Susanne May; Kellie Sheehan; Eileen M Bulger; Ahamed H Idris; Jim Christenson; Laurie J Morrison; Ralph J Frascone; Patrick L Bosarge; M Riccardo Colella; Jay Johannigman; Bryan A Cotton; Jeannie Callum; Jason McMullan; David J Dries; Brian Tibbs; Neal J Richmond; Myron L Weisfeldt; John M Tallon; John S Garrett; Martin D Zielinski; Tom P Aufderheide; Rajesh R Gandhi; Rob Schlamp; Bryce R H Robinson; Jonathan Jui; Lauren Klein; Sandro Rizoli; Mark Gamber; Michael Fleming; Jun Hwang; Laura E Vincent; Carolyn Williams; Audrey Hendrickson; Robert Simonson; Patricia Klotz; George Sopko; William Witham; Michael Ferrara; Martin A Schreiber Journal: JAMA Date: 2020-09-08 Impact factor: 56.272
Authors: Zhe Kang Law; Timothy J England; Amit K Mistri; Lisa J Woodhouse; Lesley Cala; Rob Dineen; Serefnur Ozturk; Maia Beridze; Ronan Collins; Philip M Bath; Nikola Sprigg Journal: Eur Stroke J Date: 2020-01-24